Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

38.48
Delayed Data
As of Dec 07
 +0.06 / +0.16%
Today’s Change
36.00
Today|||52-Week Range
46.22
-14.32%
Year-to-Date
Trump Claims Next Corporate Victims, AT&T-TWX Kick Off Hearing: In Case You Missed it...
Dec 07 / TheStreet.com - Paid Partner Content
MedTech Sails Through Macro Woes: Stocks in Focus
Dec 02 / Zacks.com - Paid Partner Content
Abbott Looks to Kill Alere Deal
Dec 07 / TheStreet.com - Paid Partner Content
The Best Obamacare Stocks of 2016
Nov 29 / MotleyFool.com - Paid Partner Content
Analysts' Actions -- Abbott Labs, Pandora, United Continental, More
Dec 06 / TheStreet.com - Paid Partner Content
Big Pharma healthcare R&D steps out into the open
Nov 29 / FT.com - Paid Partner Content

Today’s Trading

Previous close38.42
Today’s open38.13
Day’s range37.42 - 38.49
Volume10,888,596
Average volume (3 months)8,789,594
Market cap$56.6B
Dividend yield2.70%
Data as of 12/07/2016

Growth & Valuation

Earnings growth (last year)+18.14%
Earnings growth (this year)+2.66%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+0.78%
P/E ratio58.3
Price/Sales3.31
Price/Book2.67

Competitors

 Today’s
change
Today’s
% change
SHPGShire-7.97-4.61%
AZNAstraZeneca-0.16-0.62%
NVONovo Nordisk-0.06-0.17%
AGNAllergan-1.21-0.63%
Data as of 12/07/2016

Financials

Next reporting dateJanuary 25, 2017
EPS forecast (this quarter)$0.65
Annual revenue (last year)$20.4B
Annual profit (last year)$2.7B
Net profit margin12.67%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Miles D. White
Chief Financial Officer &
Senior VP-Finance
Brian B. Yoor
Corporate headquarters
Abbott Park, Illinois

Forecasts


Search for Jobs